Back

Risk prediction for ASCVD in primary prevention patients on statin therapy

2 September 2019 (12:40 - 13:30)
Organised by:
Congress Presentation Part of: New approaches in risk stratification Cardiovascular Risk Assessment ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Neha Pagidipati

Duke Clinical Research Institute, Durham (United States of America)

6 More presentations in this session

Presentation thumbnail
Machine learning for predicting early left ventricular abnormalities in the general population
Associate Professor T. Kuznetsova (Leuven, BE)
Abstract Slides
Presentation thumbnail
Differential associations of common risk factors and biomarkers with atrial fibrillation and heart failure and their ability to predict sequential disease onset and mortality
Doctor B. Schrage (Hamburg, DE)
Abstract Slides
Presentation thumbnail
Resting heart rate in late adolescence and long term risk of cardiomyopathy - A nationwide study of one million Swedish men
Mr M. Lindgren (Gothenburg, SE)
Abstract Slides
Presentation thumbnail
Body mass index or waist and hip circumference as predictors of outcome in the UK biobank
Doctor P. Pellicori (Glasgow, GB)
Abstract Slides
Presentation thumbnail
Body composition and mortality from vascular or metabolic causes among 150,000 participants in the Mexico City Prospective Study
Unknown L. Friedrichs (Oxford, GB)
Abstract

Access the full session

Session thumbnail
New approaches in risk stratification

The Event

Event poster

ESC Congress 2019

2 September 2019 12:40 CET
You may be interested in
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Webinar
Update on dyslipidaemia management: focus on risk estimation and lipoprotein(a)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources